Browse the evidence

Emerging therapies for genetic and syndromic obesities include approved treatments like setmelanotide and semaglutide.

Practitioners should consider the use of approved therapies like setmelanotide and semaglutide in treatment plans.

Patients with obesity are at increased risk for developing type 2 diabetes, heart attack, stroke, liver disease, and obstructive sleep apnea.

Healthcare providers should monitor and address these risks in patients with obesity.

Among 11,700 reports from July 2009 to April 2024, 13 incidents related to GLP-1 agonist use were identified, including seven cases concerning aspiration.

Clinicians should be aware of the potential aspiration risks associated with GLP-1 agonist use in the perioperative setting.

There were no differences in lean body mass gains between the peanut-based and high-carbohydrate snack groups.

Both snack types may be equally effective for increasing lean body mass in athletes.

The prevalence of low energy availability (LEA) in female collegiate beach volleyball athletes was 30.8% in the preseason, 37.5% at week 1, 25.0% at week 5, and 62.5% at week 9.

Coaches and nutritionists should monitor energy availability closely throughout the competitive season.

LEA is not a team-wide condition but an individual one.

Interventions to address LEA should be tailored to individual athletes rather than applied uniformly.

The primary outcome of the RESTART trial is a change in cardiorespiratory fitness (V̇O 2max) at 24 months.

Monitoring changes in cardiorespiratory fitness can be crucial for assessing the effectiveness of lifestyle interventions.

Weight increases of 1.0% to 2.9%, 3.0% to 4.9%, and 5.0% or greater are associated with a higher risk of type 2 diabetes by 15%, 35%, and 51%, respectively.

Weight gain should be avoided to reduce the risk of developing type 2 diabetes.

Food insecurity is associated with reduced dietary quality and excess weight gain.

Practitioners should consider the impact of food insecurity on dietary quality when addressing obesity.

There are two primary types of interventions tested for obesity among individuals with food insecurity: behavioral weight loss counseling and subsidies for food.

Interventions for obesity in food-insecure populations should include behavioral counseling and food subsidies.

Ultra processed foods are rich in sugar, fat, and sodium but poor in bioactive compounds, micronutrients, and fibers.

Practitioners should be aware of the poor nutritional profile of ultra processed foods.

The effectiveness of home-based exercise interventions is negatively influenced by inadequate dosing and adherence.

Practitioners should ensure proper dosing and encourage adherence in home exercise programs.

There are significant associations between 'high-protein and high-carbohydrate' patterns and elevated predicted 10-year CVD risk in T2D patients.

Practitioners should consider the long-term implications of dietary choices on CVD risk for patients with T2D.

Faster resistance training tempos may have a trivial advantage over slower tempos for muscle hypertrophy.

Practitioners might consider that while faster tempos could be slightly more beneficial, the difference is not significant.

Subgroup analyses indicate trivial to small effects of resistance training tempo on muscle hypertrophy under specific conditions.

Practitioners should be aware that the effects of tempo may vary based on specific training conditions.

Energy density, hyper-palatability, protein content, and eating rate significantly contribute to energy intake during meals.

Practitioners should consider these meal characteristics when assessing energy intake.

The relative importance of meal characteristics on energy intake varies by dietary pattern.

Dietary patterns should be considered when evaluating meal characteristics and energy intake.

Change in low-and no-calorie sweetened beverage (LNCSB) intake was associated with lower weight (MD, -0.008 kg/y).

Reducing LNCSB intake may help in weight management.

The primary endpoint of the study is the difference in HbA1c levels between TRE and CP at 4 months.

Monitoring HbA1c levels will be crucial for assessing the effectiveness of TRE compared to CP.

Secondary outcomes include changes in fasting glucose, fasting insulin, HOMA-IR, and nocturnal glucose.

These secondary outcomes will provide additional insights into the metabolic effects of TRE.

LLM responses had significantly higher scores than internet responses in the 'objectivity' and 'reproducibility' categories.

Practitioners may consider using LLMs for more objective and reproducible information on GLP1RA therapy.

Current therapeutic strategies for obesity include lifestyle interventions, pharmacologic treatments, and bariatric surgery.

Practitioners should consider a multi-faceted approach to obesity treatment.

Both treatments did not negatively impact fat-free mass after 3 months.

Both treatments can be used without concern for loss of lean body mass.

Most individuals who lose weight through diet and lifestyle interventions regain all or a substantial portion of the weight back within 5 years.

Practitioners should be aware that weight loss may not be sustainable for many individuals.